Abnormal 0 8 0 8 O
bone 9 13 9 13 O
marrow 14 20 14 20 O
function 21 29 21 29 O
[ 30 31 30 31 O
absolute 31 39 31 39 B-clinical_variable
neutrophil 40 50 40 50 I-clinical_variable
count 51 56 51 56 I-clinical_variable
( 57 58 57 58 I-clinical_variable
ANC)<1500 58 67 58 67 I-clinical_variable
/ 67 68 67 68 I-upper_bound
mm3 68 71 68 71 I-upper_bound
, 71 72 71 72 O
platelet 73 81 73 81 B-clinical_variable
count 82 87 82 87 I-clinical_variable
< 88 89 88 89 O
100,000 89 96 89 96 B-upper_bound
/ 96 97 96 97 I-upper_bound
mm3 97 100 97 100 I-upper_bound
, 100 101 100 101 O
hemoglobin 102 112 102 112 B-clinical_variable
< 113 114 113 114 O
9 114 115 114 115 B-upper_bound
g 116 117 116 117 I-upper_bound
/ 117 118 117 118 I-upper_bound
dL 118 120 118 120 I-upper_bound
] 120 121 120 121 O

Abnormal 0 8 122 130 O
liver 9 14 131 136 O
function 15 23 137 145 O
( 24 25 146 147 O
bilirubin 25 34 147 156 B-clinical_variable
> 35 36 157 158 O
ULN 36 39 158 161 O
; 39 40 161 162 O
AST 41 44 163 166 B-clinical_variable
, 44 45 166 167 O
ALT 46 49 168 171 B-clinical_variable
> 50 51 172 173 O
2.5 52 55 174 177 B-lower_bound
x 56 57 178 179 I-lower_bound
upper 58 63 180 185 I-lower_bound
limit 64 69 186 191 I-lower_bound
of 70 72 192 194 I-lower_bound
normal 73 79 195 201 I-lower_bound
) 79 80 201 202 O

Active 0 6 203 209 B-chronic_disease
cardiac 7 14 210 217 I-chronic_disease
disease 15 22 218 225 I-chronic_disease
defined 23 30 226 233 O
as 31 33 234 236 O
active 34 40 237 243 B-chronic_disease
angina 41 47 244 250 I-chronic_disease
, 47 48 250 251 O
symptomatic 49 60 252 263 B-chronic_disease
congestive 61 71 264 274 I-chronic_disease
heart 72 77 275 280 I-chronic_disease
failure 78 85 281 288 I-chronic_disease
, 85 86 288 289 O
or 87 89 290 292 O
myocardial 90 100 293 303 B-chronic_disease
infarction 101 111 304 314 I-chronic_disease
within 112 118 315 321 O
previous 119 127 322 330 B-upper_bound
six 128 131 331 334 I-upper_bound
months 132 138 335 341 I-upper_bound

Age 0 3 342 345 B-age
≥ 4 5 346 347 O
18 6 8 348 350 B-lower_bound
years 9 14 351 356 I-lower_bound

Antiandrogens 0 13 357 370 B-treatment
( 14 15 371 372 O
e.g. 15 19 372 376 O
bicalutamide 20 32 377 389 B-treatment
, 32 33 389 390 O
nilutamide 34 44 391 401 B-treatment
) 44 45 401 402 O

Documented 0 10 403 413 O
histologically 11 25 414 428 O
confirmed 26 35 429 438 O
adenocarcinoma 36 50 439 453 B-cancer
of 51 53 454 456 O
the 54 57 457 460 O
prostate 58 66 461 469 O

Eastern 0 7 470 477 B-clinical_variable
cooperative 8 19 478 489 I-clinical_variable
oncology 20 28 490 498 I-clinical_variable
group 29 34 499 504 I-clinical_variable
( 35 36 505 506 I-clinical_variable
ECOG 36 40 506 510 I-clinical_variable
) 40 41 510 511 I-clinical_variable
performance 42 53 512 523 I-clinical_variable
status 54 60 524 530 I-clinical_variable
≤2 61 63 531 533 O

Evidence 0 8 534 542 O
of 9 11 543 545 O
serious 12 19 546 553 O
and/or 20 26 554 560 O
unstable 27 35 561 569 O
pre 36 39 570 573 O
- 39 40 573 574 O
existing 40 48 574 582 O
medical 49 56 583 590 O
, 56 57 590 591 O
psychiatric 58 69 592 603 B-chronic_disease
or 70 72 604 606 O
other 73 78 607 612 O
condition 79 88 613 622 O
( 89 90 623 624 O
including 90 99 624 633 O
laboratory 100 110 634 644 O
abnormalities 111 124 645 658 O
) 124 125 658 659 O
that 126 130 660 664 O
could 131 136 665 670 O
interfere 137 146 671 680 O
with 147 151 681 685 O
patient 152 159 686 693 O
safety 160 166 694 700 O
or 167 169 701 703 O
provision 170 179 704 713 O
of 180 182 714 716 O
informed 183 191 717 725 O
consent 192 199 726 733 O
to 200 202 734 736 O
participate 203 214 737 748 O
in 215 217 749 751 O
this 218 222 752 756 O
study 223 228 757 762 O

Hormonal 0 8 763 771 B-treatment
therapy 9 16 772 779 I-treatment
( 17 18 780 781 O
e.g. 18 22 781 785 O
leuprolide 23 33 786 796 B-treatment
, 33 34 796 797 O
goserelin 35 44 798 807 B-treatment
, 44 45 807 808 O
triptorelin 46 57 809 820 B-treatment
, 57 58 820 821 O
degarelix 59 68 822 831 B-treatment
) 68 69 831 832 O

Prior 0 5 833 838 O
history 6 13 839 846 O
of 14 16 847 849 O
malignancy 17 27 850 860 B-cancer
in 28 30 861 863 O
the 31 34 864 867 O
past 35 39 868 872 B-upper_bound
3 40 41 873 874 I-upper_bound
years 42 47 875 880 I-upper_bound
with 48 52 881 885 O
the 53 56 886 889 O
exception 57 66 890 899 O
of 67 69 900 902 O
basal 70 75 903 908 B-cancer
cell 76 80 909 913 I-cancer
and 81 84 914 917 I-cancer
squamous 85 93 918 926 I-cancer
cell 94 98 927 931 I-cancer
carcinoma 99 108 932 941 I-cancer
of 109 111 942 944 I-cancer
the 112 115 945 948 I-cancer
skin 116 120 949 953 I-cancer
. 120 121 953 954 O
Other 122 127 955 960 O
malignancies 128 140 961 973 B-cancer
that 141 145 974 978 O
are 146 149 979 982 O
considered 150 160 983 993 O
to 161 163 994 996 O
have 164 168 997 1001 O
a 169 170 1002 1003 O
low 171 174 1004 1007 O
potential 175 184 1008 1017 O
to 185 187 1018 1020 O
progress 188 196 1021 1029 O
may 197 200 1030 1033 O
be 201 203 1034 1036 O
enrolled 204 212 1037 1045 O
at 213 215 1046 1048 O
discretion 216 226 1049 1059 O
of 227 229 1060 1062 O
PI 230 232 1063 1065 O

Prior 0 5 1066 1071 B-treatment
local 6 11 1072 1077 I-treatment
non 12 15 1078 1081 I-treatment
- 15 16 1081 1082 I-treatment
surgical 16 24 1082 1090 I-treatment
therapy 25 32 1091 1098 I-treatment
to 33 35 1099 1101 O
treat 36 41 1102 1107 O
prostate 42 50 1108 1116 B-cancer
cancer 51 57 1117 1123 I-cancer
( 58 59 1124 1125 O
e.g. 59 63 1125 1129 O
radiation 64 73 1130 1139 B-treatment
therapy 74 81 1140 1147 I-treatment
, 81 82 1147 1148 O
brachytherapy 83 96 1149 1162 B-treatment
) 96 97 1162 1163 O

Prior 0 5 1164 1169 O
or 6 8 1170 1172 O
ongoing 9 16 1173 1180 O
systemic 17 25 1181 1189 B-treatment
therapy 26 33 1190 1197 I-treatment
for 34 37 1198 1201 O
prostate 38 46 1202 1210 B-cancer
cancer 47 53 1211 1217 I-cancer

hormone 0 7 1218 1225 B-treatment
therapy 8 15 1226 1233 I-treatment
was 16 19 1234 1237 O
recently 20 28 1238 1246 O
initiated 29 38 1247 1256 O
( 39 40 1257 1258 O
< 40 41 1258 1259 O
90 41 43 1259 1261 B-upper_bound
days 44 48 1262 1266 I-upper_bound
duration 49 57 1267 1275 O
) 57 58 1275 1276 O
) 58 59 1276 1277 O

